By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



204 2nd Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


Medical Device

Company News
Augmenix Announces First Prostate Cancer Patients Treated With Spaceoar Hydrogel In Israel 6/29/2017 7:01:38 AM
Augmenix Release: SpaceOAR System Receives Shonin Approval In Japan 5/31/2017 7:17:53 AM
Augmenix Announces First Prostate Cancer Patient Treated With SpaceOAR Hydrogel In Canada 5/2/2017 8:19:50 AM
Augmenix Release: Phase 3 Trial Data Show Use Of SpaceOAR Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment 2/24/2017 9:25:32 AM
Augmenix Release: Company Announces Positive Three-Year Long-Term Data Highlighting Benefits Of Spaceoar Hydrogel Spacer For Patients With Prostate Cancer 1/12/2017 9:53:45 AM
Augmenix Announces New Category 1 CPT Code From The American Medical Association For Periprostatic Implantation Of Biodegradable Material 11/9/2016 9:02:34 AM
Augmenix Announces Positive Spaceoar Clinical Trial Results Demonstrating Superior Outcomes At 3-Years 9/27/2016 10:51:38 AM
Augmenix Financing Will Enable Sales Growth 7/13/2016 10:49:00 AM
Augmenix Announces The Publication Of The Spaceoar Hydrogel Pivotal Clinical Study Results: Application Technique And Patient Tolerance In Men Undergoing Prostate Cancer Radiotherapy 3/31/2016 10:58:31 AM
Augmenix’ SpaceOAR System Experiences Rapid U.S. Adoption 10/15/2015 11:09:31 AM